Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study

by Denise Heady,University of California, Los AngelesProstate cancer cells. Credit: NIH Image GalleryA team of UCLA Health Jonsson Comprehensive Cancer Center investigators has shown the combina

Updated on: March 30,2024

Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study

by Denise Heady,University of California, Los AngelesProstate cancer cells. Credit: NIH Image GalleryA team of UCLA Health Jonsson Comprehensive Cancer Center investigators has shown the combina

Updated on:March 30,2024

Chronic diseases monitored in primary care could lead to unnecessary testing

by University of BristolCredit: CC0 Public DomainGuidelines used by GPs to monitor chronic diseases are based on expert opinion rather than evidence, according to a review of the guidelines by Na

Updated on: May 05,2024

Chronic diseases monitored in primary care could lead to unnecessary testing

by University of BristolCredit: CC0 Public DomainGuidelines used by GPs to monitor chronic diseases are based on expert opinion rather than evidence, according to a review of the guidelines by Na

Updated on:May 05,2024

Researchers examine role of fluid flow in ovarian cancer progression

by Virginia TechAfter multiple rounds of fluid shear stress exposure, human cells in the study began to form tumor-like structures known as spheroids (pictured). Spheroids are indicative of aggre

Updated on: June 15,2024

Researchers examine role of fluid flow in ovarian cancer progression

by Virginia TechAfter multiple rounds of fluid shear stress exposure, human cells in the study began to form tumor-like structures known as spheroids (pictured). Spheroids are indicative of aggre

Updated on:June 15,2024

Simulating your cancer treatment on a computer

by University of OsloArnoldo Frigessi is the main person behind the new idea of making tens of thousands of virtual copies of the individual cancer patient and then testing all the treatments in

Updated on: April 23,2024

Simulating your cancer treatment on a computer

by University of OsloArnoldo Frigessi is the main person behind the new idea of making tens of thousands of virtual copies of the individual cancer patient and then testing all the treatments in

Updated on:April 23,2024

New model predicts 10-year breast cancer risk

byUniversity of OxfordSmoothed calibration plots of the alignment between predicted and observed risks for each of the models The red lines correspond to the calibration curve, with the red shad

Updated on: January 15,2024

New model predicts 10-year breast cancer risk

byUniversity of OxfordSmoothed calibration plots of the alignment between predicted and observed risks for each of the models The red lines correspond to the calibration curve, with the red shad

Updated on:January 15,2024

'Dual-target' cell therapy appears to shrink brain tumors, research finds

by Perelman School of Medicine at the University of PennsylvaniaCredit: Anna Shvets from PexelsTargeting two brain tumor-associated proteins—rather than one—with CAR T cell therapy shows promise

Updated on: March 20,2024

'Dual-target' cell therapy appears to shrink brain tumors, research finds

by Perelman School of Medicine at the University of PennsylvaniaCredit: Anna Shvets from PexelsTargeting two brain tumor-associated proteins—rather than one—with CAR T cell therapy shows promise

Updated on:March 20,2024

A new drug target identified for diseases associated with leukemia-causing virus

by Christine Yu,Pennsylvania State UniversityKDR inhibition induces autophagic/lysosomal degradation of Tax. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-49737-5A team

Updated on: August 06,2024

A new drug target identified for diseases associated with leukemia-causing virus

by Christine Yu,Pennsylvania State UniversityKDR inhibition induces autophagic/lysosomal degradation of Tax. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-49737-5A team

Updated on:August 06,2024

Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment

byDana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.10.017For many patients with a condition that often precedes multiple myeloma, e

Updated on: January 02,2024

Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment

byDana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.10.017For many patients with a condition that often precedes multiple myeloma, e

Updated on:January 02,2024

Biochemists, cancer biologists find key vulnerability in rare brain tumors

by Anne Manning,Colorado State UniversityCredit: Pixabay/CC0 Public DomainSince the start of her career, Jennifer DeLuca has been fascinated by mitosis, the everyday biological process of cell d

Updated on: January 04,2024

Biochemists, cancer biologists find key vulnerability in rare brain tumors

by Anne Manning,Colorado State UniversityCredit: Pixabay/CC0 Public DomainSince the start of her career, Jennifer DeLuca has been fascinated by mitosis, the everyday biological process of cell d

Updated on:January 04,2024

Researchers discover how bacteria make pancreatic cancer cells grow and move

by Virginia TechPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteVirginia Tech researchers from the Department of Biomedical Enginee

Updated on: January 30,2024

Researchers discover how bacteria make pancreatic cancer cells grow and move

by Virginia TechPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteVirginia Tech researchers from the Department of Biomedical Enginee

Updated on:January 30,2024

Targeted cancer drug made available for some NHS liver cancer patients

by Cancer Research UKCredit: CC0 Public DomainA targeted cancer drug will now be available for some adults with advanced liver cancer on the NHS.Regorafenib (Stivarga) is to be offered to people

Updated on: March 09,2024

Targeted cancer drug made available for some NHS liver cancer patients

by Cancer Research UKCredit: CC0 Public DomainA targeted cancer drug will now be available for some adults with advanced liver cancer on the NHS.Regorafenib (Stivarga) is to be offered to people

Updated on:March 09,2024

Adding tucatinib to drug combination extends survival for advanced HER2+ breast cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center today reported study results showing the addition of

Updated on: April 23,2024

Adding tucatinib to drug combination extends survival for advanced HER2+ breast cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center today reported study results showing the addition of

Updated on:April 23,2024